Back to Agenda
How AI and Protocol Data Standards can enable improved patient-centric study designs
Session Chair(s)
William Illis, MPH
Executive Director, Technology and Scientific Computing
Novartis , United States
Clinical trial start-up is often delayed by manual processes, fragmented systems, and inconsistent data. This workshop will explore how biopharmaceutical companies are using AI and interoperable data standards to enable patient centric study designs.
Learning Objective : Explain how AI and USDM (the CDISC digital protocol data standard) work together to streamline study design and protocol development; Discuss wasy to achieve patient-centric design and reduced patient burdens using AI in conjunction with clinical standards; Examine how data standards enable interoperability and multi-stakeholder collaboration including with sites and patients.
Have an account?